Indication

Acute Intermittent

1 clinical trial

2 products

Clinical trial

ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias

Status: Completed, Estimated PCD: 2019-01-31

Product

Product